apheris AI

apheris AI builds federated AI for the pharmaceutical industry. It was founded by Robin Röhm and Michael Höh, who set out to let companies run analytics on data that stays in separate locations.

What apheris AI offers

• AI structural biology network — protein-complex and co-folding models trained across biopharma data.
• ADMET prediction — models to improve small-molecule property predictions on new chemistry.
• Antibody R&D — federated training on purpose-built datasets, in collaboration with Ginkgo Datapoints.
• Real-world evidence — federated analysis across distributed healthcare data sources.
• Apheris Foundry — delivers models into customer programmes, running in the customer's own environment.

Who it works with

The company works with pharmaceutical and biotech organisations and says its network includes five pharma partners.

Key facts

• Founders: Robin Röhm and Michael Höh
• Focus: federated data networks for drug discovery